{"url_path":"/sec/prof/8-k/2026-05-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1628808/0001104659-26-062509-index.html","accession_number":"0001104659-26-062509","cik":"0001628808","ticker":"PROF","issuer_name":"Profound Medical Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1628808/0001104659-26-062509-index.html","primary_entity_key":"0001628808","primary_entity_name":"Profound Medical Corp."},"word_count":71,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nExhibit No.Description\n\n  \n\n[99.1](tm2614840d1_ex99-1.htm)[Management Information Circular](tm2614840d1_ex99-1.htm)\n\n  \n\n104Cover Page Interactive Data File (embedded within the Inline XBRL\ndocument)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**PROFOUND MEDICAL CORP.**\n\n \n \n \n\nDate: May 15, 2026\nBy:\n/s/ Rashed Dewan\n\n \n \nRashed Dewan\n\nChief Financial Officer"}